Clinical Data
Tonix Pharmaceuticals Abandons Depression Drug Post-Phase 2 Failure
Anika Sharma
Tonix Pharmaceuticals has experienced a setback in its pipeline as it discontinues the development of a major depression disorder (MDD) ...
Araclon’s Alzheimer’s vaccine shows promise in phase 2 trial
Anika Sharma
Araclon Biotech, a subsidiary of Grifols, has unveiled promising early evidence regarding the effectiveness of its Alzheimer’s disease vaccine. In ...
Relay postpones its rare cancer drug approval plans due to IRA, losing ground to competitors
Anika Sharma
Relay Therapeutics is altering its strategic course, driven by the effects of the Inflation Reduction Act (IRA), leading the biotech ...
Seagen’s Tukysa Demonstrates Trial Victory in Breast Cancer, Amplifying Roche’s Kadcyla and Significance in Light of Pfizer’s $43B Acquisition
Anika Sharma
In a strategic move, Pfizer has announced a hefty investment of $43 billion to acquire Seagen, with a keen focus ...
